 |
JOURNAL TOOLS |
| Opzioni di pubblicazione |
| eTOC |
| Per abbonarsi |
| Sottometti un articolo |
| Segnala alla tua biblioteca |
ARTICLE TOOLS |
| Publication history |
| Estratti |
| Permessi |
| Per citare questo articolo |
| Share |
I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
LETTERS TO THE EDITOR
Minerva Endocrinologica 2020 September;45(3):273-5
DOI: 10.23736/S0391-1977.20.03122-3
Copyright © 2020 EDIZIONI MINERVA MEDICA
lingua: Inglese
Sitagliptin relieves diabetic nephropathy fibrosis via the MAPK/ERK signaling pathway
Shufeng CHENG 1, Liang LI 2, Chunquan SONG 3, Huijing JIN 4, Shouguo MA 5, Ping KANG 6 ✉
1 Department of Nephrology, People’s Hospital of Zhangqiu Area, Jinan, China; 2 Department of Pharmacy, Yidu Central Hospital, Weifang, China; 3 Department of Pharmacy, Qingdao Central Hospital, Qingdao, China; 4 Ward Department, People’s Hospital of Zhangqiu Area, Jinan, China; 5 Department of Burn and Plastic Surgery, People’s Hospital of Zhangqiu Area, Jinan, China; 6 Department of Rehabilitation, People’s Hospital of Zhangqiu Area, Jinan, China